Xanax recalled nationwide. What you need to know
perigon
Last updated: April 18, 2026
A specific allotment of the medication Xanax, commonly used for anxiety and panic disorders, has been recalled. The recall is due to the medication's potential to cause adverse effects. This action impacts patients who may have received the affected batches.
- The recall specifically concerns Xanax (alprazolam) tablets manufactured by Mylan Institutional LLC. This action was initiated due to the presence of a foreign substance, identified as budesonide, found in the API (Active Pharmaceutical Ingredient) of the recalled batches. Budesonide is a corticosteroid, typically used to treat conditions like asthma and inflammatory bowel disease, and is not an ingredient in Xanax.
- The affected product is Xanax 0.5 mg, 25-count bottles, with NDC 0055-0105-53, lot number 9336334, and expiration date 2025-07-31. This recall is a voluntary action taken by the manufacturer. Patients currently taking the recalled medication are advised to contact their doctor or healthcare provider to discuss alternative treatments and to obtain a new prescription. They should not discontinue use of Xanax without consulting a healthcare professional. The recall aims to prevent potential patient exposure to the unintended substance and ensure the safety and efficacy of the prescribed medication.
